RheothRx Injection: Partner Burroughs Well-come began Phase I trial to test whether RheothRx increases the efficacy of Alkeran by enhancing tumor blood flow and

CytRx Corp. (CYTR) Product: RheothRx Injection Indication: Adjunct to chemotherapy in combination with Burroughs Wellcome's Alkeran in patients with advanced ovarian cancer who have failed first-line...